Insight Molecular Diagnostics Inc. Business Acquisition, Equity Interest Issued or Issuable, Value Assigned
Insight Molecular Diagnostics Inc. (IMDX) had Business Acquisition, Equity Interest Issued or Issuable, Value Assigned of $5.00 million as of 2020-01-31, per its 10-Q filed 2021-05-17.
Discontinued › Notes › Business Combination, Asset Acquisition, Transaction between Entities under Common Control, and Joint Venture Formation
us-gaap:BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned · last filed 2021-05-17
- 2020-01-31: Business Acquisition, Equity Interest Issued or Issuable, Value Assigned $5.00M.
| Period end | Business Acquisition, Equity Interest Issued or Issuable, Value Assigned |
|---|---|
| 2020-01-31 | $5.00M 10-Q · filed 2021-05-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |